Civil society letter by Oxfam & 82 other organisations- Open Letter to WHO member states (March 6)
In this letter, Oxfam & 82 civil society organizations urge all WHO Member States to support actions to improve the transparency of medical R&D, prices, patents & clinical trials.
FT – Kelly Chibale: Overcoming sceptics at home and abroad
“Founder of H3D is debunking the idea that Africa cannot be a leader in drug discovery”.
“… The rag in Kelly Chibale’s rags-to-riches story is the lit one he used to put into a paraffin-filled tub so that he could study at night. Brought up amid violence and squalor in the Zambian copper belt settlement of Kabulanda — whose name, he says, literally denotes “sadness” — Mr Chibale has fashioned a successful career from a tough start. The 54-year-old is the founder and director of H3D, Africa’s only fully integrated drug discovery centre, which in 2017 became the first to put an “African drug” — an anti-malarial — into Phase II clinical trials. A member of the Royal Society of Chemistry, in 2018 he was named by Fortune as one of the world’s top 50 leaders….”
HPW – Delay Vote On Cannabis Reclassification – Chair Of UN Commission On Narcotic Drugs Recommends
“The UN Commission on Narcotic Drugs appears set to delay any consideration this year of a recent World Health Organization recommendation to reschedule the status of cannabis and cannabis-related substances from “particularly dangerous” to a less dangerous category – with no timeline indicated for when the Commission might actually take up the contentious issue….”